Embattled Ariad CEO To Step Down In Sarissa Deal
Ariad Pharmaceuticals Inc. said Wednesday that it has settled its proxy battle with Sarissa Capital Management LP and that Harvey J. Berger, the drugmaker's founder, chairman and CEO, will retire....To view the full article, register now.
Already a subscriber? Click here to view full article